Dr. Irfan A. Agha, MD

Dr. Agha practices at U.S. Renal Care North Dallas Dialysis in Rockwall, Texas.

Dr. Agha's NPI, 1912982489, was assigned on December 7, 2005. Dr. Agha graduated from Army Medical College Quaid-e-Azam Univ in 1991. Dr. Agha holds Texas license M2240.

Dr. Agha's primary practice is U.S. Renal Care North Dallas Dialysis, at 519 E I-30, Rockwall, TX 75087 in Rockwall County. The practice phone is (469) 518-6772.

Dr. Agha's primary practice is U.S. Renal Care North Dallas Dialysis in Rockwall, Texas. Dr. Agha is also affiliated with Medical City Dallas Hospital. The medical group on file is Concord Medical Group. Dmand AI also links Dr. Agha to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agha practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Agha's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Agha is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Agha's licenses on file in 2 states: Texas and Missouri.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Agha treats.

CMS data shows 179 Medicare services from Dr. Agha across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $14,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Agha in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agha's median patient age at 56, with 50% women.

In 2024, Dr. Agha wrote 300 Medicare Part D claims for 33 patients. 85% of them were for generic drugs. CMS names the drug for 146 of them, across 8 drugs with 11 or more claims each, at $19,204 in total drug cost. In 2023, CMS named 220 claims across 12 drugs.

Dr. Agha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agha as offering telehealth.

Dmand AI links 7 papers to Dr. Agha, published from 2016 to 2025. The most frequent topics are Kidney Transplantation, Graft Rejection and Immunosuppression Therapy. Dr. Agha's most frequent co-authors are Tarek Alhamad, MD, Jonathan Scott Bromberg, MD and Christine Marie Durand.

Dmand AI links Dr. Agha to 4 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Glomerulonephritis, IGA, Glomerulonephritis and Polycystic Kidney, Autosomal Dominant.

CMS Open Payments shows 594 general payments to Dr. Agha from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. GlaxoSmithKline, LLC. paid the most, $272,010.

Dr. Agha graduated from Army Medical College Quaid-e-Azam Univ in 1991.

Dr. Agha is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.